Coronary artery disease after heart transplantation and its relation to cytomegalovirus

American Heart Journal

Volumn 138, Issue 5 II, 1999, Pages

  Hosenpud, J D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0032693809     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70277-2     Document Type: Conference Paper

References (35)

1. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J Heart Lung Transplant 1992;11:9-23.
2. Oni AA, Ray J, Hosenpud JD. Coronary venous intimal thickening in explanted cardiac allografts: evidence demonstrating that transplant coronary artery disease is a manifestation of a diffuse allograft vasculopathy. Transplantation 1992;53:1247-51.
3. Liu G, Butany J. Morphology of graft arteriosclerosis in cardiac transplant recipients. Hum Pathol 1992;23:768-73.
4. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts, I: time course and immunogenetic and immunopathologic considerations. Am J Pathol 1994;144:260-74.
5. Atkinson JB, Wudel JH, Hoff SJ, et al. Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts. J Heart Lung Transplant 1993;12:1036-43.
6. Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopathy: association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995;92:205-11.
7. Rose EA, Smith CR, Petrossian GA, et al. Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 1989;106:203-8.
8. Smith JD, Danskine AJ, Rose ML, et al. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation 1992;53:1358-62.
9. Grattan MT, Moreno-Cabral CE, Starnes VA, et al. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
10. Loebe M, Schuler S, Zais O, et al. Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 1990;9:707-11.
11. McDonald K, Rector TS, Braunlin EA, et al. Association of coronary artery disease in cardiac transplant patients with cytomegalovirus infection. Am J Cardiol 1989;64:359-62.
12. Balk A, Linden M, Meeter K, et al. Is there a relation between transplant coronary artery disease and the occurrence of CMV infection [abstract]? J Heart Lung Transplant 1991;10:188.
13. Koskinen PK, Nieminen MS, Krogerus LA, et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993;12:724-9.
14. Everett JP, Hersberger RE, Norman DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992;11:S133-7.
15. Wu T-C, Hruban RH, Ambinder RF, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992;140:739-47.
16. Lemstrom KB, Bruning JH, Bruggeman CA, et al. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J Clin Invest 1993;92:549-58.
17. Lemstrom KB, Raisanen-Sokolowski AK, Hayry PJ, et al. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol 1996;16:553-64.
18. Lemstrom KB, Bruning JH, Bruggeman CA, et al. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation 1994;90:1969-78.
19. Sedmak DD, Roberts WH, Stephens RE, et al. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression. Transplantation 1990;49(2):458-62.
20. van Dorp WT, Jones E, Bruggeman CA, et al. Direct induction of MHC class I, but not class II expression on endothelial cells by cytomegalovirus. Transplantation 1989;48(3):469-72.
21. VanDam-Mieras MCE, Bruggeman CA, Muller AD, et al. Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 1987;47(1):69-75.
22. Span AHM, Endert J, van Boven CPA, et al. Virus induced adherence of monocytes to endothelial cells. FEMS Microbiol Immunol 1989;47:237-41.
23. Waldman WJ, Adams PW, Orosz CG, et al. T lymphocyte activation by cytomegalovirus-infected, allogeneic cultured human endothelial cells. Transplantation 1992;54(5):887-96.
24. Ho DD, Rota TR, Andrews CA, et al. Replication of human cytomegalovirus in endothelial cells. J Infect Dis 1984;150(6):956-7.
25. Hosenpud JD, Chou S, Wagner CR. Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells. Transplantation 1991;52(5):896-903.
26. Wong TW, Warner NE. Cytomegalic inclusion disease in adults. Arch Pathol 1962;74:409-22.
27. Myerson D, Hackman RC, Nelson JA, et al. Widespread presence of histologically occult cytomegalovirus. Hum Pathol 1984;15:430-9.
28. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990;50:537-54.
29. Minick CR, Fabricam CG, Fabricam J, et al. Atheroarteriosclerosis induced by infection with a herpes virus. Am J Pathol 1979;96(3):673-706.
30. Tumilowicz JJ, Gawlik ME, Powell BB, et al. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 1985;56:839-45.
31. Tumilowicz JJ. Characteristics of human arterial smooth muscle cell cultures infected with cytomegalovirus. In Vitro Cell Dev Biol 1990;26:1144-50.
32. Arkonac B, Mauck KA, Chou S, et al. Low multiplicity cytomegalovirus infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology. J Heart Lung Transplant 1997;16:1034-45.
33. Halloran P, Batiuk T, Goes N. An overview of the cytokines in transplantation. Transplantation Sci 1993;3:69-76.
34. Fontana A, Constam DB, Frei K, et al. Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Immunol 1992;99:1-7.
35. Murray AG, Libby P, Pober JS. Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. J Immunol 1995;154:151-61.